The Australian
Australia’s Recce strives for immune-proof super-antibiotic Introductory offers to be billed as follows: The Australian Digital Subscription costs 50c per day, billed monthly (min cost up…
BioWorld
BioWorld
Recce nears clinic with ‘master key’ antibiotic to take on superbugs PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based…
Fighting Antibiotic Resistance
Fighting Antibiotic Resistance
The world needs new classes of antibiotics Antibiotics
The world needs new classes of antibiotics Antibiotics are used as our frontline treatment…
Nature Biopharma
Nature Biopharma
New class of synthetic antibiotics set to tackle superbugs PERTH, Australia – A new class of synthetic antibiotics with broad-spectrum activity is being developed by Sydney-based…
Coronavirus crisis
Coronavirus crisis
Recce Pharmaceuticals is among dozens of WA-founded biotech companies that are making serious waves in the medical research sector, with COVID-19 the latest disease in its sights…
The Australian – Research Special Report 2020
The Australian – Research Special Report 2020
A revolutionary approach to medicine: synthetic anti-Infectives Anti-infectives are used as our frontline treatment for everyday and life threatening bacteria and viral infections…
Pharmafiles 2020: Synthetic Anti-Infectives
Pharmafiles 2020: Synthetic Anti-Infectives
AMR is a ticking time bomb argues Recce CEO James Graham…
H.C. Wainwright Global Life Sciences Conference
H.C. Wainwright Global Life Sciences Conference
Click here for full Press Release and Presentation
AusBiotech Journal 2020 Vol 30
AusBiotech Journal 2020 Vol 30
A NEW CLASS OF ANTIBIOTICS
AusBiotech Journal 2020 Vol 30
AusBiotech Journal 2020 Vol 30
ADVANCING THE ‘ARMS RACE’ against antibiotic-resistant superbugs